Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

  • Catharina Müller-Thomas
  • , Martina Rudelius
  • , Ina Christine Rondak
  • , Torsten Haferlach
  • , Julie Schanz
  • , Christina Huberle
  • , Burkhard Schmidt
  • , Rainer Blaser
  • , Marcus Kremer
  • , Christian Peschel
  • , Ulrich Germing
  • , Uwe Platzbecker
  • , Katharina Götze

Research output: Contribution to journalLetterpeer-review

56 Scopus citations
Original languageEnglish
Pages (from-to)e179-e181
JournalHaematologica
Volume99
Issue number10
DOIs
StatePublished - 1 Oct 2014

Keywords

  • Azacitidine
  • MDS
  • TP53 mutations
  • p53 expression

Cite this